Indrani Sarkar

2.2k total citations · 1 hit paper
65 papers, 1.6k citations indexed

About

Indrani Sarkar is a scholar working on Molecular Biology, Plant Science and Oncology. According to data from OpenAlex, Indrani Sarkar has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Plant Science and 11 papers in Oncology. Recurrent topics in Indrani Sarkar's work include Genomics and Phylogenetic Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Legume Nitrogen Fixing Symbiosis (8 papers). Indrani Sarkar is often cited by papers focused on Genomics and Phylogenetic Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Legume Nitrogen Fixing Symbiosis (8 papers). Indrani Sarkar collaborates with scholars based in India, United States and Tunisia. Indrani Sarkar's co-authors include Carol O’Hear, Marcella Fassò, Luciana Molinero, Fadi Braiteh, Frank Buchholz, Ilona Hauber, Joachim Hauber, Michael S. Gordon, William Grossman and Joseph P. Eder and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Indrani Sarkar

60 papers receiving 1.5k citations

Hit Papers

Long-term Clinical Outcomes and Biomarker Analyses of Ate... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indrani Sarkar India 17 898 423 385 371 155 65 1.6k
Qian-Jin Zhang China 19 289 0.3× 499 1.2× 338 0.9× 111 0.3× 116 0.7× 47 1.2k
Ángel M. García‐Lora Spain 27 1.2k 1.3× 699 1.7× 1.6k 4.2× 175 0.5× 171 1.1× 57 2.5k
Ning Yang China 23 274 0.3× 628 1.5× 491 1.3× 122 0.3× 174 1.1× 71 1.6k
Édith Beaulieu Canada 21 578 0.6× 529 1.3× 165 0.4× 127 0.3× 303 2.0× 35 1.6k
Brian J. Morrison United States 20 489 0.5× 357 0.8× 354 0.9× 111 0.3× 188 1.2× 46 1.2k
Jeremy O. Jones United States 24 433 0.5× 783 1.9× 303 0.8× 627 1.7× 453 2.9× 73 1.9k
Jeng‐Wei Lu Taiwan 24 210 0.2× 759 1.8× 177 0.5× 109 0.3× 313 2.0× 95 1.6k
Shuvomoy Banerjee India 24 610 0.7× 523 1.2× 322 0.8× 43 0.1× 120 0.8× 44 1.3k
Yun Wu China 20 203 0.2× 663 1.6× 167 0.4× 156 0.4× 305 2.0× 61 1.2k
Mozaffarul Islam United States 20 450 0.5× 532 1.3× 199 0.5× 107 0.3× 311 2.0× 26 1.4k

Countries citing papers authored by Indrani Sarkar

Since Specialization
Citations

This map shows the geographic impact of Indrani Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indrani Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indrani Sarkar more than expected).

Fields of papers citing papers by Indrani Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indrani Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indrani Sarkar. The network helps show where Indrani Sarkar may publish in the future.

Co-authorship network of co-authors of Indrani Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Indrani Sarkar. A scholar is included among the top collaborators of Indrani Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indrani Sarkar. Indrani Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Oral, Evrim, Indrani Sarkar, Vlad C. Sandulache, et al.. (2024). Rate of occult metastasis in lip squamous cell carcinoma: A systematic review and meta‐analysis. Head & Neck. 46(10). 2517–2523.
4.
Sarkar, Indrani, et al.. (2023). Complete mitogenome of common myna (Acridotheres tristis) – characterization and phylogenetic implications. Biologia. 78(4). 1079–1091. 1 indexed citations
5.
Sarkar, Indrani, et al.. (2023). Probing the Assembly of Nicotinuric Acid with Alpha and Beta Cyclodextrin Molecules by Physiochemical Investigation and Computational Approach. Journal of Chemical Biological and Physical Sciences. 13(4). 1 indexed citations
6.
Kar, Pallab, Devashan Naidoo, Ayan Roy, et al.. (2022). Synthesis of silver nanoparticles from secondary metabolites of star gooseberry fruit (Phyllanthus acidus) and their nephroprotective efficiency. South African Journal of Botany. 151. 385–395. 4 indexed citations
7.
Sen, Gargi, Sandipan Ghosh, Indrani Sarkar, & Arnab Sen. (2022). Persepectives on Extremophilic Actinobacteria - A Review. 14(1). 1–7. 1 indexed citations
8.
Petrylak, Daniel P., Yohann Loriot, David R. Shaffer, et al.. (2021). Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study. Clinical Cancer Research. 27(12). 3360–3369. 54 indexed citations
9.
Sarkar, Indrani, et al.. (2021). Complete mitogenome of endemic plum-headed parakeet Psittacula cyanocephala – characterization and phylogenetic analysis. PLoS ONE. 16(4). e0241098–e0241098. 8 indexed citations
10.
Roy, Ayan, Arnab Sen, Sourav Chakraborty, & Indrani Sarkar. (2021). Correction to: Comprehensive profiling of functional attributes, virulence potential and evolutionary dynamics in mycobacterial secretomes. World Journal of Microbiology and Biotechnology. 37(1). 10–10. 1 indexed citations
11.
Hamid, Omid, Luciana Molinero, Christopher R. Bolen, et al.. (2019). Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab. Clinical Cancer Research. 25(20). 6061–6072. 58 indexed citations
12.
Dey, Priyankar, et al.. (2019). Oleander Stem and Root Standardized Extracts Mitigate Acute Hyperglycaemia by Limiting Systemic Oxidative Stress Response in Diabetic Mice. Advances in Pharmacological Sciences. 2019. 1–12. 11 indexed citations
13.
Rudin, Charles M., Andrés Cervantes, Afshin Dowlati, et al.. (2018). MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC. Journal of Thoracic Oncology. 13(10). S407–S407. 26 indexed citations
14.
Sen, Arnab, Louis S. Tisa, Maher Gtari, & Indrani Sarkar. (2018). Contrasted evolutionary constraints on carbohydrate active enzymes (CAZymes) in selected Frankia strains. Antonie van Leeuwenhoek. 112(1). 115–125. 2 indexed citations
15.
Sarkar, Indrani, et al.. (2018). Comparative genomics of Mycobacterium reveals evolutionary trends of M. avium complex. Genomics. 111(3). 426–435. 5 indexed citations
16.
Colevas, A. Dimitrios, Rastislav Bahleda, Fadi Braiteh, et al.. (2018). Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial. Annals of Oncology. 29(11). 2247–2253. 107 indexed citations
18.
Rudin, Charles M., Andrés Cervantes, Afshin Dowlati, et al.. (2017). P3.02c-046 Safety, Clinical Activity and Biomarker Results from a Phase Ib Study of Erlotinib plus Atezolizumab in Advanced NSCLC. Journal of Thoracic Oncology. 12(1). S1302–S1303. 11 indexed citations
19.
Sarkar, Indrani, et al.. (2017). Comparative evolutionary genomics of Corynebacterium with special reference to codon and amino acid usage diversities. Genetica. 146(1). 13–27. 5 indexed citations
20.
Roy, Ayan, et al.. (2015). Comparative investigation of the various determinants that influence the codon and amino acid usage patterns in the genus Bifidobacterium. World Journal of Microbiology and Biotechnology. 31(6). 959–981. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026